China 3415-08-5 L-Tyr-NCA Moetsi le Fektheri |Jiayinglai

3415-08-5 L-Tyr-NCA

Tlhaloso e Khutšoanyane:

Ponahalo	Likristale tse tšoeu ho isa ho tse tšoeu kapa phofo ea crystalline
MF	C10H9NO4
MW	207.18
Bohloeki	98+

Re romelle lengolo-tsoibila

Lintlha tsa Sehlahisoa

Boemo ba lipalangoang&mokhoa oa ho romella o khothalelitsoeng:
ka moya, ka lewatle kapa ka polelo

Boemo ba polokelo:
nert atmosphere, Boloka ka sehatsetsing, ka tlas'a -20°C

Bonyane Bonyane ba Odara:
Puisano

Setifikeiti:
COA, HPLC, GC, HNMR, Assay, Water Content(KF), TLC e teng

Litlhaloso tse tšoanang

Tyrosine, NCA;

N-Carboxy-L-tyrosine anhydride;

(4S) -4 - [(4-Hydroxyphenyl)methyl] -2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl]-, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

Ho paka ka hare

Hangata li sebelisoa ho paka phofo.'Me li ka thibela khanya ea letsatsi le metsi hore li se ke tsa senyeha.

ho phuthela ka ntle

Lebokose le thata le ka sireletsa lihlahisoa tsa hau ho senya le ho koloba.

Lisebelisoa

3415-08-5 L-Tyr-NCA ke e 'ngoe ea li-intermediates tsa Glatiramer Acetate.

Glatiramer Acetate ke moemeli oa peptide o entsoeng ka maiketsetso o entsoeng ka li-amino acid tse 'nè: glutamic acid, alanine, tyrosine, le lysine.Tšebeliso ea eona e ka sehloohong e itšetlehile ka phekolo ea Multiple Sclerosis (MS), boloetse bo sa foleng, bo bakoang ke ho ruruha, bo senyang bo amang tsamaiso ea methapo e bohareng.Ka mochine oa "khatello ea "bypass," Glatiramer Acetate e fana ka liphello tsa immunomodulatory le anti-inflammatory ho MS, ho eketsa maemo a boko-derived neurotrophic factor (BDNF), ho fokotsa ho fokotseha ho bakoang ke ho ruruha, le ho khothalletsa kholo ea li-axon le li-sheath tsa myelin.

Lefatšeng ka bophara, Glatiramer Acetate e fumane ts'ebeliso e atileng.Ka mohlala, United States, e rekisoa tlas'a lebitso la Copaxone 'me e amohetsoe ke Tsamaiso ea Lijo le Lithethefatsi (FDA) bakeng sa phekolo ea Multiple Sclerosis.Linaheng tsa Bophirimela tse nang le ts'oaetso e phahameng ea MS, ho sebetsa ha eona le ho mamelloa ha eona ho 'nile ha tsejoa hohle.

China, ka la 28 Phuptjane 2023, "Glatiramer Acetate Injection" e amohetse tumello ka molao ho tsoa ho National Medical Products Administration (NMPA) bakeng sa kalafo ea bakuli ba baholo ba nang le lefu la ho khutla la Multiple Sclerosis (MS), ho kenyeletsoa le lefu le le leng le le leng le le leng le le leng le le leng, le khutlela morao. MS, le MS e tsoelang pele ea bobeli e sebetsang.

lihlahisoa tse amanang

L-Gly-NCA	L-Ala-NCA	D-Ala-NCA	L-Val-NCA
D-Leu-NCA	DL-leu-NCA	L-Phe-NCA	D-Tyr-NCA
L-Tyr(bzl)-NCA	L-Glu(Obzl)-NCA	D-Asp(OBzl)-NCA	L-Ls(tfa)-NCA
L-Ls(Cbz)-NCA	D-Ls(Cbz)-NCA	Sar-NCA

Boemo bo phahameng

1. Tshebeletso ya R&D e teng
2. Moetsi ea netefalitsoeng oa ISO, tiiso ea boleng
3.Tsamaiso e feletseng ea ts'ebeletso ea ho latela nakong ea tlhahiso
4.Chelete e phahameng e atlehang
5.Litokomane tsa setifikeiti sa boleng tse fanoeng ho latela kopo ea moreki
Tšebeletso ea 6.E kholo ka mor'a thekiso, ho boloka kamano e haufi le moreki
7.Mohloli o felletseng oa ho thusa ho fokotsa litšenyehelo tsa ho tsamaisa thepa
8.Free sampole e filwe ho hlahloba tsoa boleng pele ho tefo efe kapa efe
9.Ho buisanoa ka nako ea tefo
Bareki ba 10.Assit ba sebetsana le litaba tsa China